Montu

What Montu does

Montu Group Pty Ltd is an Australian privately held health tech company founded in 2019 by Christopher Strauch and headquartered in Melbourne. It operates the country's largest fully integrated medical cannabis ecosystem, comprising four wholly owned subsidiaries: Alternaleaf (a telehealth clinic serving 150,000+ patients annually), Leafio (a wholesale distribution network providing next-day delivery to 3,000–4,000+ pharmacies with 100+ brands and 1,000+ products), uMeds (a pharmacy dispensing-as-a-service fulfillment layer), and SAGED (an accredited clinical education platform for healthcare professionals). The underlying technology stack centers on a telehealth platform with integrated patient management, advanced logistics and supply management tooling, and an automated prescription-to-dispensing workflow that closes the gap between prescriber, pharmacy, and patient.

Montu generates revenue through four streams: per-consultation telehealth fees (Alternaleaf), wholesale product margins and distribution fees (Leafio), per-order pharmacy dispensing fees (uMeds), and product sales across six distinct medical cannabis brands. The go-to-market combines product-led patient acquisition via telehealth, channel partnerships with major international cannabis suppliers (Organigram, Aurora Cannabis via MedReleaf Australia), and active government and regulatory engagement through the Telehealth Sector Working Group and TGA submissions. Recognized as Australia's fastest-growing tech company in both 2022 and 2023 by Deloitte Tech Fast 50—achieving measured revenue growth of 20,700% and 9,600% respectively as the first back-to-back winner in the program's history—Montu now operates with 501–1,000 employees, has delivered 450,000+ lifetime practitioner consultations, and is positioned as the largest medical cannabis company outside North America.

Name

Montu

Legal name

Montu Group Pty Ltd

Website

https://montu.com.au

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Montu is Australia's largest integrated medical cannabis ecosystem, operating telehealth consultations (Alternaleaf), wholesale distribution (Leafio), pharmacy fulfillment (uMeds), and clinical education (SAGED) for 150,000+ annual patients and 3,000+ pharmacy partners.

Ownership category

akta.pro rank

Product category

Medical Cannabis Healthcare Services

NAICS

Pharmacies and Drug Retailers (45611), Pharmacies and Drug Retailers (456110), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Retail-Drug Stores And Proprietary Stores (5912), Pharmaceutical Preparations (2834)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

akta.pro secondary industries

Medical Cannabis Dispensaries (CRANAFAB), Medical Cannabis Delivery & Online Ordering (CRANAGAG), Cannabis Accessories & Ancillary Products Wholesale (Vapes, Packaging, Hardware) (CRAOAIAH)

Keywords

• Medical cannabis telehealth
• Cannabis distribution services
• Pharmacy fulfillment solutions
• Clinical cannabis education
• Patient care platform

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Telehealth Consultations: Alternaleaf provides telehealth consultations to patients seeking medical cannabis treatment, generating revenue through consultation fees for initial and follow-up appointments with doctors and nurses.
2. Wholesale Distribution: Leafio serves as Montu's wholesale distribution arm, distributing medical cannabis products to pharmacies nationwide with next-day delivery, generating revenue through product margins and distribution fees.
3. Pharmacy Fulfilment: uMeds provides dispensing-as-a-service to partner pharmacies, handling prescriptions and delivery logistics, generating revenue through dispensing fees and per-order basis medication handling.
4. Medical Cannabis Products: Montu distributes pharmaceutical medicines including oral oils, flower strains, vape carts, and premium rosin concentrates across 6 distinct brands through its integrated ecosystem.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Montu operates a fully integrated health tech ecosystem for medical cannabis in Australia, spanning patient-facing telehealth consultations through Alternaleaf, wholesale distribution of cannabis products to pharmacies via Leafio, dispensing-as-a-service pharmacy fulfillment through uMeds, and accredited clinical education for healthcare professionals via SAGED. The company also distributes its own portfolio of medicinal cannabis products across six distinct brands (oral oils, flower, vape cartridges, and rosin concentrates).

Product overview

Montu is a platform-plus-modules health tech ecosystem with a fully integrated structure spanning multiple distinct brands and services. The core platform encompasses Alternaleaf (telehealth clinic), Leafio (distribution network), uMeds (pharmacy fulfillment), and SAGED (clinical education). These modules work together: Alternaleaf connects patients with clinicians via telehealth, uMeds handles prescription dispensing and delivery, Leafio manages wholesale distribution to pharmacies, and SAGED provides accredited education for healthcare professionals. Additional offerings include government relations, patient advocacy, clinical governance, real-world evidence research, and pharmacovigilance services. Across 6 distinct brands, Montu offers a full suite of high-quality medicinal cannabis products from oral oils to flower strains, vape carts, and premium rosin concentrates.

Differentiator

Problem solved

Functional benefit

Brands

• Alternaleaf: Australia’s trusted alternative health clinic offering telehealth services to more than 150,000+ patients annually through innovative online clinical model.
• Leafio
• uMeds
• SAGED

Products and services

• Alternaleaf

Quantifiable outcome

• 450,000+ practitioner consults to date
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Leafio (Montu Australia wholesale division)coreChannel Partner/ Reseller/ Distributor · 24 February 2026Leafio serves as Montu's wholesale distribution arm, partnering with cannabis companies like Organigram to distribute medical cannabis products (Edison and BOXHOT vapes and pastilles) to over 4,000 pharmacies across Australia through next-day delivery.
• Department of Health / Australian Digital Health AgencycoreOthers · 20 January 2026Telehealth Sector Working Group, spearheaded by Montu, published a report calling on the Australian government to implement mandatory telehealth regulations. Report outlines CARE principles covering clinical care, administrative operations, resourcing, and ethical standards.
• MedReleaf Australia (Aurora Cannabis subsidiary)coreChannel Partner/ Reseller/ Distributor · 8 December 2025New distribution partnership between Aurora Cannabis (via MedReleaf Australia subsidiary) and Leafio (Montu's wholesale division) to expand medical cannabis distribution through Australian pharmacy network.
• Telehealth Sector Working GroupcoreStrategic or Co-development Partner · 5 May 2025Montu convenes a working group to develop a telehealth code of practice and core governance principles for the rapidly expanding telehealth industry. Former Health Minister Greg Hunt appointed as independent chairman to lobby for regulatory change.
• Rare Cancers AustraliaminorOthers · 23 January 2025Montu participates in the annual Kosi Challenge, climbing Mount Kosciuszko to raise funds and awareness for Australians living with rare, less common, and complex cancers. Rare cancers account for one in four cancer diagnoses but over half of cancer deaths.
• Partner Pharmacies (3,000+)coreChannel Partner/ Reseller/ DistributorOver 3,000 pharmacies nationwide partner with Montu's Leafio distribution network and uMeds fulfilment services, creating Australia's fastest growing medical cannabis distribution network.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Althea Group Holdings: Australian medicinal cannabis company with a vertically integrated platform spanning cultivation, manufacturing, distribution and telehealth. Closest direct peer to Montu given overlapping Australian medical cannabis footprint and similar integrated model.
• Little Green Pharma: Australian-based medicinal cannabis producer and distributor with its own patient and prescriber channels. Comparable to Montu in target market (Australian medical cannabis patients), product offering (oils and flowers), and channel strategy (pharmacy distribution).
• Bod Australia: Australian medicinal cannabis and CBD wellness company with a focus on patient access, pharmacy distribution and product development. Direct competitor in the Australian medical cannabis market serving similar patient and pharmacy channels as Montu.
• Cann Group Limited: Australian medicinal cannabis cultivator and manufacturer supplying pharmacy and patient channels. Overlaps with Montu on the supply side of the Australian medical cannabis value chain that Montu's Leafio distribution platform serves.
• Vitura Health (formerly Cronos Australia): Australian medical cannabis distributor and telehealth operator. Direct competitor to Montu's Alternaleaf and Leafio businesses, serving the same patient and pharmacy network in Australia.
• ECS Botanics Holdings: Australian medicinal cannabis cultivator and manufacturer with a focus on pharmacy and patient distribution. Comparable Australian medical cannabis market participant overlapping with Montu's distribution and product portfolio.

Emerging players

• Aurora Cannabis: Global cannabis producer and a current Montu distribution partner (via MedReleaf Australia) that could evolve into a direct competitor in Australia by building its own pharmacy distribution and telehealth capabilities.
• Organigram Holdings: Global cannabis producer that distributes through Leafio (Edison, BOXHOT brands) in Australia. As a current partner with global reach, represents both a key supplier and a potential future direct competitor to Montu.

Broad incumbents

• Curaleaf Holdings: Large US multi-state vertically integrated cannabis operator with dispensary, distribution and telehealth components. Broad incumbent reference for the integrated cannabis ecosystem model Montu is building in Australia.
• Tilray Brands: Global cannabis leader with cultivation, distribution and patient-facing channels across multiple geographies. Relevant broader incumbent peer for evaluating Montu's strategic position and potential international expansion benchmarks.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/montugroup
• YouTubeyoutube.com/channel/UCRfpt3TisIkS6MGevI7C_2g
• Facebookfacebook.com/MontuAustralia
• LinkedInlinkedin.com/company/montu-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Montu